株式会社スカイライト・バイオテック

Skylight Biotech provides solutions for research, prevention and diagnosis in lifestyle-related diseases.

株式会社スカイライト・バイオテック is a business in insurtech based in Tokyo, Japan.

Profile

"Skylight Biotech is a leading Insurtech company specializing in solutions for research, prevention, and diagnosis of lifestyle-related diseases. Through their preventive healthcare support services, Skylight Biotech conducts research and provides testing services for new biomarkers that assess the risk of metabolic syndrome and atherosclerosis in self-paying patients. Their flagship testing service, MetaboCHART, offers precise analysis of small LDL particles in health check-ups, enabling early detection of metabolic syndrome and atherosclerosis risk based on data on "ultra-bad cholesterol" and LDL particle size. By quantifying previously challenging data on "ultra-bad cholesterol" and particle size, Skylight Biotech's detailed analysis aids in risk assessment and is presented in a chart format for patients. Skylight Biotech's innovative approach to disease prevention and early detection contributes significantly to the healthcare industry's advancement."

Its activity falls under insurtech; the profile below is assembled from public directory data.

Tokyo, Japan is where the company is located.

Directory data places it at the Plug and Play portfolio startup stage.

The company reports a headcount in the 1-10 range.

Website: skylight-biotech.com/clinical-support-services